Tessera
Folgen

Dionysios (Dennis) Watson

@dionysioswatson.bsky.social

Physician-scientist @UnivMiami dedicated to developing next-generation cancer therapies targeting the tumor microenvironment

14 Posts831 Follower82 Folgt
Nature Reviews Cancer@natrevcancer.nature.com · 3mo ago

#ResearchHighlight 🚨 Glioblastoma exhibits sex-specific differences in disease progression, incidence & immune regulation. Pathak et al. identify GABA as a key driver of granulocytic MDSC-mediated glioblastoma progression in women. 👇

GABA takes the edge off anti-tumour immunity - Nature Reviews Cancer

Glioblastoma exhibits sex-specific differences in disease progression, incidence and immune regulation. Now, Pathak et al. identify GABA (γ-aminobutyric acid) as a key driver of granulocytic myeloid-derived suppressor cell-mediated glioblastoma progression in women.

dlvr.it

WEHI (The Walter and Eliza Hall Institute of Medical Research)@wehi-research.bsky.social · 7mo ago

The close research collaboration between WEHI and MSD used the advanced screening technologies at the National Drug Discovery Centre, headquartered at WEHI, which were instrumental in identifying and optimising the compound. www.wehi.edu.au/collaborativ... 🧵2/2

National Drug Discovery Centre | WEHI

The NDDC accelerates drug discovery with screening technologies, partnering with researchers to find new treatments for mental health, malaria, and more

wehi.edu.au

Dionysios (Dennis) Watson@dionysioswatson.bsky.social · 10mo ago

Are probiotics ready for prime time in cancer immunotherapy? Read out new review to find out! 👇 🪅 Congratulations to the trainee-led team that put this together! @janichinmay.bsky.social and others at Sylvester Comprehensive Cancer Center, University of Miami www.frontiersin.org/journals/imm...

Frontiers | Leveraging beneficial microbiome-immune interactions via probiotic use in cancer immunotherapy

The gut microbiome is a critical regulator of systemic immunity and a major modulator of response to cancer immunotherapy with immune checkpoint inhibitors (...

frontiersin.org

Dionysios (Dennis) Watson@dionysioswatson.bsky.social · last yr.

🚨 Attention immunologists 💉: We are seeking a postdoctoral fellow to lead projects on tumor-targeted cytokines and bacterial extracellular vesicles for cancer immunotherapy (focus - brain and lung cancers). 😎 🏖️ University of Miami www.DiscoverTME.com . Please DM if interested.

DiscoverTME lab | Therapeutics targeting tumor microenvironment interactions

DiscoverTME is a biomedical research laboratory at Sylvester Comprehensive Cancer Center, University of Miami, FL

discovertme.com

Dionysios (Dennis) Watson@dionysioswatson.bsky.social · 2y ago

With 2024 drawing to a close, @naturecancer.bsky.social released a small collection of #NewPI Viewpoints on starting a new lab. Check it out for a peek into our #UMiami laboratory at #SylvesterComprehensiveCancerCenter rdcu.be/d3R8r

The 2024 generation

Nature Cancer - Twelve early-career researchers who embarked on their independent research paths in 2024 reflect on their experience from their journey so far, describe the opportunities they...

rdcu.be

Dionysios (Dennis) Watson@dionysioswatson.bsky.social · 2y ago

Congratulations to both! Looking forward to seeing this project develop. Great privilege to co-mentor @j-mitchell.bsky.social with @dbayik.bsky.social

Defne Bayik@dbayik.bsky.social · 2y ago

Celebrating lab’s 2nd anniversary with the first successful QE from @j-mitchell.bsky.social 🥂🍾🎊! Congrats! Cheers to an amazing lab @orianateran.bsky.social @pathaka.bsky.social @brandonleon95.bsky.social along with the partner lab @dionysioswatson.bsky.social @iremkaraman.bsky.social

Nature Portfolio@natureportfolio.nature.com · 2y ago

Researchers in India fought to develop what could have been the first therapy to use gene-editing to halt a rare neurodegenerative disease. Nature reports on how the efforts hold lessons for the messy state of modern drug development. 🧪

Hope, despair and CRISPR — the race to save one woman’s life

Researchers in India fought to develop what could have been the first therapy to use gene-editing to halt a rare neurodegenerative disease. The efforts hold lessons for the messy state of modern drug ...

go.nature.com